Insulin therapy for adult patients with type 2 diabetes mellitus: A position statement of the Korean diabetes association, 2017

on behalf of the Committee of Clinical Practice Guideline of Korean Diabetes Association

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

Original languageEnglish
Pages (from-to)367-373
Number of pages7
JournalDiabetes and Metabolism Journal
Volume41
Issue number5
DOIs
Publication statusPublished - 2017 Oct 1

Keywords

  • Clinical practice guideline
  • Diabetes mellitus
  • Hypoglycemic agents
  • Insulin
  • Korea
  • Type 2

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Insulin therapy for adult patients with type 2 diabetes mellitus: A position statement of the Korean diabetes association, 2017'. Together they form a unique fingerprint.

  • Cite this